RA
Therapeutic Areas
Charleston Laboratories Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CL-108 | Moderate to Severe Acute Pain with prevention/reduction of Opioid-Induced Nausea and Vomiting (OINV) | NDA Resubmitted |
| Drug | Indication | Phase |
|---|---|---|
| CL-108 | Moderate to Severe Acute Pain with prevention/reduction of Opioid-Induced Nausea and Vomiting (OINV) | NDA Resubmitted |